Clinical Trial Update: A Thorough EKG Safety Study of TA-1790 (Avanafil) [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating the ECG/EKG safety of TA-1790 (Avanafil) in men with erectile dysfunction. The study has completed and summarizes preliminary safety fi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Erectile Dysfunction

Drugs mentioned

• TA-1790 (Avanafil) (Avanafil)

Snippet

Sponsor: VIVUS LLC | Conditions: Erectile Dysfunction | Phase 1 | Status: COMPLETED